Manulife (Manufacturers Life Insurance)
VERV

Manulife (Manufacturers Life Insurance)’s Verve Therapeutics VERV Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,926
Closed -$280K – 2997
2025
Q2 		$280K Sell
24,926
-975
-4% -$5.56K ﹤0.01% 2413
2025
Q1 		$118K Sell
25,901
-737
-3% -$4.94K ﹤0.01% 2656
2024
Q4 		$150K Sell
26,638
-656
-2% -$3.7K ﹤0.01% 2718
2024
Q3 		$132K Sell
27,294
-811
-3% -$4.71K ﹤0.01% 2787
2024
Q2 		$137K Buy
28,105
+4,759
+20% +$29.9K ﹤0.01% 2736
2024
Q1 		$310K Sell
23,346
-2,329
-9% -$30.9K ﹤0.01% 2386
2023
Q4 		$358K Buy
25,675
+823
+3% +$10.2K ﹤0.01% 2319
2023
Q3 		$330K Buy
24,852
+4,113
+20% +$66.2K ﹤0.01% 2327
2023
Q2 		$389K Buy
20,739
+1,904
+10% +$31.7K ﹤0.01% 2196
2023
Q1 		$272K Sell
18,835
-73
-0.4% -$1.43K ﹤0.01% 2365
2022
Q4 		$366K Buy
18,908
+3,721
+25% +$98.6K ﹤0.01% 2179
2022
Q3 		$522K Sell
15,187
-255
-2% -$8.14K ﹤0.01% 1955
2022
Q2 		$236K Buy
15,442
+578
+4% +$8.95K ﹤0.01% 2539
2022
Q1 		$339K Buy
14,864
+5,961
+67% +$170K ﹤0.01% 2439
2021
Q4 		$328 Buy
8,903
+474
+6% +$19.9K ﹤0.01% 2548
2021
Q3 		$396K Buy
+8,429
New +$496K ﹤0.01% 2458

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s VERV Position: Q3 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 24,926 shares — an estimated $280K sold.

Manulife (Manufacturers Life Insurance) first reported a position in VERV in Q3 2021 and held it in 16 quarters. The position peaked at $522K in Q3 2022. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 24,926 Verve Therapeutics shares in Q3 2025, an estimated $280K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Verve Therapeutics in Q3 2021 and held it in 16 quarters.
  • Manulife (Manufacturers Life Insurance)'s Verve Therapeutics position peaked at $522K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2025, filed 14 Nov 2025.